Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex311_9.htm |
| EX-10.37 - EX-10.37 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex1037_645.htm |
| EX-32.1 - EX-32.1 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex321_7.htm |
| EX-32.2 - EX-32.2 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex322_6.htm |
| EX-31.2 - EX-31.2 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex312_10.htm |
| EX-10.49 - EX-10.49 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex1049_647.htm |
| EX-10.32 - EX-10.32 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex1032_644.htm |
| EX-10.18 - EX-10.18 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex1018_994.htm |
| EX-10.47 - EX-10.47 - FIVE PRIME THERAPEUTICS, INC. | fprx-ex1047_646.htm |
| 10-K - 10-K - FIVE PRIME THERAPEUTICS, INC. | fprx-10k_20151231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-204131) of Five Prime Therapeutics, Inc.,
(2) Registration Statement (Form S-3 No. 333-200067) of Five Prime Therapeutics, Inc.,
(3) Registration Statement (Form S-8 No. 333-202854) pertaining to the 2013 Omnibus Incentive Plan and the 2013 Employee Stock Purchase Plan of Five Prime Therapeutics, Inc., and
(3) Registration Statement (Form S-8 No. 333-194820) pertaining to the 2013 Omnibus Incentive Plan and the 2013 Employee Stock Purchase Plan of Five Prime Therapeutics, Inc.;
of our report dated March 11, 2016, with respect to the financial statements of Five Prime Therapeutics, Inc. included in this Annual Report (Form 10-K) of Five Prime Therapeutics, Inc. for the year ended December 31, 2015.
/s/ Ernst & Young LLP
San Jose, California
March 11, 2016